CALR and amyotrophic lateral sclerosis: A calcium-binding ER chaperone calreticulin is reduced in SMN vulnerable to ALS [45], and further reduction of calreticulin levels by breeding hSOD1G93A mice with hemizygous calreticulin mutant mice accelerated disease onset and progression [40].